Virus-positive samples (n = 41) | Virus-negative samples (n = 146) | P value | |
---|---|---|---|
Age (years) | 63.2 ± 16.1 | 62.9 ± 14.5 | 0.91 |
Male | 31 (75.6) | 103 (70.5) | 0.53 |
Comorbidities | |||
Chronic obstructive pulmonary disease/asthma | 16 (39.0) | 23 (15.7) | 0.0012 |
Cardiologic disease | 37 (90.2) | 124 (84.9) | 0.38 |
Chronic use of steroids | 8 (19.5) | 17 (11.6) | 0.19 |
Neoplasia | 2 (4.9) | 13 (8.9) | 0.53 |
Immunosupressive drugs | 2 (4.8) | 6 (4.1) | 1.0 |
Neutropenia < 1,000/mm3 | 0 | 2 (1.4) | 1.0 |
Community admission | 29 (70.7) | 98 (67.1) | 0.66 |
Admission between 21 November and 21 March | 23 (56.1) | 45 (30.8) | 0.003 |
Reason for intensive care unit admission | |||
Respiratory disordera | 33 (75.6) | 89 (61.0) | 0.03 |
Septic shock | 6 (14.6) | 21 (14.4) | 1.0 |
Cardiogenic shock or cardiac arrest | 2 (4.9) | 36 (24.7) | 0.004 |
Comatose | 3 (7.3) | 24 (16.4) | 0.2 |
Other | 3 (7.3) | 15 (10.3) | 0.78 |
Acute Physiology and Chronic Health Evaluation type II score | 18.0 ± 9.3 | 20.9 ± 8.3 | 0.057 |
Simplified Acute Physiology Score II | 46.8 ± 18.9 | 51.5 ± 17.3 | 0.13 |
Logistic organ dysfunction system | 6.8 ± 3.9 | 7.8 ± 3.8 | 0.14 |